OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Adrenoceptors in the Retina
Yue Ruan, Tobias Böhmer, Subao Jiang, et al.
Cells (2020) Vol. 9, Iss. 12, pp. 2594-2594
Open Access | Times Cited: 15

Showing 15 citing articles:

Retinopathy of prematurity: A review of pathophysiology and signaling pathways
Mariza Fevereiro‐Martins, Carlos Marques‐Neves, Hercília Guimarães, et al.
Survey of Ophthalmology (2022) Vol. 68, Iss. 2, pp. 175-210
Open Access | Times Cited: 51

Exploring the Antioxidant and Anti-Inflammatory Potential of Saffron (Crocus sativus) Tepals Extract within the Circular Bioeconomy
Luisa Frusciante, Michela Geminiani, Behnaz Shabab, et al.
Antioxidants (2024) Vol. 13, Iss. 9, pp. 1082-1082
Open Access | Times Cited: 7

The β3 adrenoceptor in proliferative retinopathies: “Cinderella” steps out of its family shadow
Maurizio Cammalleri, Rosario Amato, Massimo Dal Monte, et al.
Pharmacological Research (2023) Vol. 190, pp. 106713-106713
Open Access | Times Cited: 11

Scientific rationale for the use of α2A-adrenoceptor agonists in treating neuroinflammatory cognitive disorders
Amy F.T. Arnsten, Yumiko Ishizawa, Zhongcong Xie
Molecular Psychiatry (2023) Vol. 28, Iss. 11, pp. 4540-4552
Open Access | Times Cited: 11

α1D Adrenergic Receptor Antagonism Protects Against High Glucose-Induced Mitochondrial Dysfunction and Blood Retinal Barrier Breakdown in ARPE-19 Cells
Erika Giuffrida, Chiara Bianca Maria Platania, Francesca Lazzara, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 967-967
Open Access

The Role of Beta-Adrenergic Receptors in Depression and Resilience
Hongxing Zhang, Mengqiao Cui, Jun‐Li Cao, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2378-2378
Open Access | Times Cited: 13

β-Adrenoreceptors as Therapeutic Targets for Ocular Tumors and Other Eye Diseases—Historical Aspects and Nowadays Understanding
Elsa Wilma Böhm, Bernhard Stoffelns, Adrian Gericke
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4698-4698
Open Access | Times Cited: 7

Regulation of Adrenergic, Serotonin, and Dopamine Receptors to Inhibit Diabetic Retinopathy: Monotherapies versus Combination Therapies
Timothy S. Kern, Yunpeng Du, Jie Tang, et al.
Molecular Pharmacology (2021) Vol. 100, Iss. 5, pp. 470-479
Open Access | Times Cited: 17

Impact of dexmedetomidine as an adjuvant to peribulbar anesthesia on the retinal vasculature in glaucoma patients: an optical coherence tomography angiography study
Mohamed Awwad, Mona Ahmed Elhadad, Mohamed Masoud
Journal of the Egyptian Ophthalmological Society (2024) Vol. 117, Iss. 3, pp. 202-216
Open Access

Timolol maleate, a β blocker eye drop, improved edema in a retinal vein occlusion model.
Shinichiro Fuma, Yae Hidaka, Anri Nishinaka, et al.
PubMed (2023) Vol. 29, pp. 188-196
Closed Access | Times Cited: 1

The β3‐Adrenergic Receptor: Structure, Physiopathology of Disease, and Emerging Therapeutic Potential
Julius T. Dongdem, Axandrah E Etornam, Solomon Beletaa, et al.
Advances in Pharmacological and Pharmaceutical Sciences (2024) Vol. 2024, Iss. 1
Open Access

Experimental research in rats on the reactivity of new corneal blood vessels to adrenaline
Daniela Damian, Mihai Ghiță, Sânziana Istrate, et al.
Romanian Journal of Ophthalmology (2021) Vol. 65, Iss. 1, pp. 64-69
Open Access | Times Cited: 3

Preclinical Evaluation of a Novel Once-a-Day Brimonidine Ophthalmic Nanosuspension
Ajay J. Khopade, Arindam Halder, Vivek Patel, et al.
Journal of Ocular Pharmacology and Therapeutics (2023) Vol. 39, Iss. 9, pp. 631-642
Closed Access

Page 1

Scroll to top